Get the Stockscreener App
1.81
2.84%
0.05
Fibrobiologics Inc Stock (FBLG) Forecast
The Fibrobiologics Inc (FBLG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $96.05, representing a +5,206% increase from the current price of $1.81. The highest analyst price target is $105.85, and the lowest is $86.24.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FBLG Price Target
Average 119.47
(+6,501% Upside)
Is Fibrobiologics Inc (FBLG) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 76.44 | Sell |
| STOCH(9,6) | 68.20 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.118 | Buy |
| ADX(14) | 37.60 | Buy |
| William %R | -6.7891 | Sell |
| CCI(14) | 110.77 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.141
Buy
|
1.1584
Buy
|
| MA20 |
0.9619
Buy
|
1.0435
Buy
|
| MA50 |
0.8818
Buy
|
1.0569
Buy
|
| MA100 |
1.066
Buy
|
1.764
Sell
|
| MA200 |
3.5217
Sell
|
4.1702
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, FBLG could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 6 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on FBLG, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 76.44 indicates that FBLG is overbought. This suggests that FBLG price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 68.2 indicates that FBLG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that FBLG is oversold. This suggests that FBLG price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.6 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 110.77 indicates that FBLG is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term FBLG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Fibrobiologics Inc financial reports and earnings history, Fibrobiologics Inc (FBLG) stock could reach $269.30 by 2030, $946.94 by 2040 and $730.28 by 2050. See the projected annual prices until 2050 of the Fibrobiologics Inc stock below:
- Fibrobiologics Inc (FBLG) is expected to reach an average price of $270.39 in 2035, with a high prediction of $328.29 and a low estimate of $212.48. This indicates an $14,838% rise from the last recorded price of $1.81.
- Fibrobiologics Inc (FBLG) stock is projected to chart a bullish course in 2040, with an average price target of $847.65, representing an $46,731% surge from its current level. The forecast ranges from a conservative $848.76 to a sky-high $946.94.
- Our analysts predict Fibrobiologics Inc (FBLG) to jump 42,125% by 2045, soaring from $764.44 to an average price of $764.27, potentially reaching $936.24. While $764.44 is the low estimate, the potential upside is significant.
- Fibrobiologics Inc (FBLG) stock is expected to climb by 2050, reaching an average of $624.90, a $34,425% jump from its current level. However, a wide range of estimates exists, with high and low targets of $730.28 and $519.53, respectively, highlighting the market's uncertainty.
Fibrobiologics Inc Stock (FBLG) Year by Year Forecast
Fibrobiologics Inc Stock (FBLG) Price Forecast for 2026
The predicted value for Fibrobiologics Inc (FBLG) in 2026 is set at an average of $93.44. Estimates vary from a peak of $154.62 to a trough of $32.26, indicating an +5,063% surge from the present price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2026 | $86.07 | $86.24 | $105.85 | +4,656% |
| November, 2026 | $57.78 | $58.28 | $77.76 | +3,093% |
| December, 2026 | $167.33 | $45.61 | $154.62 | +9,145% |
Fibrobiologics Inc Stock (FBLG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Fibrobiologics Inc (FBLG) is $132.49, with a high forecast of $212.70 and a low forecast of $52.28. This indicates an +7,220% increase from the last price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $128.61 | $129.33 | $148.32 | +7,005% |
| February, 2027 | $98.19 | $98.36 | $120.68 | +5,325% |
| March, 2027 | $58.80 | $58.89 | $88.96 | +3,149% |
| April, 2027 | $186.69 | $52.28 | $173.98 | +10,214% |
| May, 2027 | $144.34 | $145.06 | $166.77 | +7,875% |
| June, 2027 | $101.03 | $101.78 | $135.50 | +5,482% |
| July, 2027 | $66.38 | $66.47 | $91.42 | +3,567% |
| August, 2027 | $206.05 | $58.96 | $193.34 | +11,284% |
| September, 2027 | $152.47 | $154.11 | $185.22 | +8,324% |
| October, 2027 | $112.23 | $112.98 | $140.40 | +6,101% |
| November, 2027 | $73.96 | $74.05 | $101.72 | +3,986% |
| December, 2027 | $207.93 | $65.63 | $212.70 | +11,388% |
Fibrobiologics Inc Stock (FBLG) Price Forecast for 2028
In 2028, Fibrobiologics Inc (FBLG) is projected to reach an average price of $171.54, with a high projection of $270.77 and a low estimate of $72.31. This indicates an +9,377% rise from the last price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $167.30 | $168.94 | $196.06 | +9,143% |
| February, 2028 | $123.44 | $124.19 | $154.32 | +6,720% |
| March, 2028 | $92.16 | $72.31 | $112.01 | +4,992% |
| April, 2028 | $226.38 | $233.35 | $232.06 | +12,407% |
| May, 2028 | $170.95 | $171.49 | $213.61 | +9,345% |
| June, 2028 | $123.19 | $123.42 | $156.60 | +6,706% |
| July, 2028 | $94.67 | $78.98 | $110.36 | +5,130% |
| August, 2028 | $233.53 | $234.64 | $251.41 | +12,802% |
| September, 2028 | $184.87 | $185.41 | $218.26 | +10,114% |
| October, 2028 | $133.49 | $133.72 | $169.62 | +7,275% |
| November, 2028 | $288.45 | $85.66 | $262.55 | +15,836% |
| December, 2028 | $251.07 | $252.18 | $270.77 | +13,771% |
Fibrobiologics Inc Stock (FBLG) Price Forecast for 2029
The 2029 price forecast for Fibrobiologics Inc Stock (FBLG) is $210.59 on average, with a high prediction of $328.85 and a low estimate of $92.33. This represents an +11,535% increase from the previous price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $183.26 | $186.26 | $234.90 | +10,025% |
| February, 2029 | $130.74 | $131.71 | $169.62 | +7,123% |
| March, 2029 | $309.62 | $92.33 | $283.72 | +17,006% |
| April, 2029 | $268.62 | $269.73 | $290.13 | +14,741% |
| May, 2029 | $196.27 | $199.27 | $251.54 | +10,744% |
| June, 2029 | $140.13 | $141.10 | $181.73 | +7,642% |
| July, 2029 | $330.79 | $99.01 | $304.89 | +18,176% |
| August, 2029 | $269.83 | $271.04 | $309.49 | +14,807% |
| September, 2029 | $209.29 | $212.29 | $253.56 | +11,463% |
| October, 2029 | $134.17 | $134.67 | $193.84 | +7,312% |
| November, 2029 | $349.75 | $105.68 | $326.06 | +19,223% |
| December, 2029 | $286.47 | $287.69 | $328.85 | +15,727% |
Fibrobiologics Inc Stock (FBLG) Price Forecast for 2030
Fibrobiologics Inc Stock (FBLG) is expected to reach an average price of $250.96 in 2030, with a high forecast of $389.57 and a low forecast of $112.36. This signifies an +13,765% surge from the last price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $207.18 | $207.35 | $269.30 | +11,346% |
| February, 2030 | $142.65 | $143.15 | $189.80 | +7,781% |
| March, 2030 | $370.02 | $112.36 | $347.23 | +20,343% |
| April, 2030 | $303.11 | $304.33 | $348.20 | +16,646% |
| May, 2030 | $219.29 | $219.46 | $285.03 | +12,016% |
| June, 2030 | $151.14 | $151.64 | $201.01 | +8,250% |
| July, 2030 | $380.27 | $119.03 | $368.40 | +20,910% |
| August, 2030 | $301.69 | $302.41 | $351.29 | +16,568% |
| September, 2030 | $231.40 | $231.57 | $283.79 | +12,685% |
| October, 2030 | $142.19 | $142.28 | $212.21 | +7,756% |
| November, 2030 | $399.63 | $125.71 | $389.57 | +21,979% |
| December, 2030 | $317.42 | $318.14 | $369.75 | +17,437% |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):